Oral presentations
Mathias Due Buron(Rigshospitalet), Per Soelberg Sørensen(University of Copenhagen), Melinda Magyari(University of Copenhagen), P. V. Rasmussen(Aarhus University Hospital), Anna Tsakiri(University of Southern Denmark), Zsolt Illés(Universität Hamburg), Homayoun Roshanisefat(University of Southern Denmark), Thor Petersen(Aarhus University Hospital), Houry Hassanpour-Kalam-Roudy(University of Southern Denmark), Thor Ameri Chalmer(Rigshospitalet), Zoltán Mezei(University of Debrecen), Finn Sellebjerg(Danish Multiple Sclerosis Center)
Cited by 8
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Multiple Sclerosis Severity Score
|Neurology|2005|957